following the successfuldevelopment of innovative drugallisartan isoproxil tablets (xinlitan) for hypertension, we have been developingsacubitril allisartan calcium and two compound preparations, being committed tobringing new drug choices to patients with hypertension. up to date, several genericproducts for treatment of hypertension have received “highly equivalent to theinnovatives” from nampa based on their high quality profiles.
xindayue